10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables and software for single cell and spatial biology systems. Its single cell portfolio, powered by Chromium platform, includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Visium Spatial Gene Expression, and others.
äŒæ¥ã³ãŒãTXG
äŒç€Ÿå10X Genomics Inc
äžå Žæ¥Sep 12, 2019
æé«çµå¶è²¬ä»»è
ãCEOãSaxonov (Serge Wilson)
åŸæ¥å¡æ°1306
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Sep 12
æ¬ç€Ÿæåšå°6230 Stoneridge Mall Road
éœåžPLEASANTON
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœUnited States of America
éµäŸ¿çªå·94588
é»è©±çªå·19254017300
ãŠã§ããµã€ãhttps://www.10xgenomics.com/
äŒæ¥ã³ãŒãTXG
äžå Žæ¥Sep 12, 2019
æé«çµå¶è²¬ä»»è
ãCEOãSaxonov (Serge Wilson)